Robinson Jennifer D, Johnson Nancy, Brand-Eubanks Damianne C, Kim Anne P
J Am Pharm Assoc (2003). 2021 May-Jun;61(3):e75-e77. doi: 10.1016/j.japh.2020.11.010. Epub 2020 Dec 7.
Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way.
由于冠状病毒病（COVID-19）大流行的广泛性及其在全球范围内的影响，行为健康状况的存在和影响可能会增加。例如，预计由于COVID-19造成的持续干扰，患有重度抑郁症的个体可能会占到总人口的60%之多。2017年，经历重度抑郁发作的个体年发生率仅为7.1%。药剂师，尤其是社区药剂师，具备为患有心理健康疾病并与之抗争的个体提供所需干预和分诊服务的良好条件。因此，药剂师需要额外的培训和支持，以便能有效地以这种方式服务社区。
